BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32454076)

  • 1. Investigation of the susceptibility of Candida auris and Candida albicans to chemical disinfectants using European Standards EN 13624 and EN 16615.
    Müller P; Tan CK; Ißleib U; Paßvogel L; Eilts B; Steinhauer K
    J Hosp Infect; 2020 Aug; 105(4):648-656. PubMed ID: 32454076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris.
    Moore G; Schelenz S; Borman AM; Johnson EM; Brown CS
    J Hosp Infect; 2017 Dec; 97(4):371-375. PubMed ID: 28865738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of octenidine- and chlorhexidine-based wash-mitts against Candida albicans and Candida auris - a comparative study.
    Gugsch F; Tan CK; Oh DY; Paßvogel L; Steinhauer K
    J Hosp Infect; 2024 Jan; 143():91-96. PubMed ID: 37949371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial efficacy and compatibility of solid copper alloys with chemical disinfectants.
    Steinhauer K; Meyer S; Pfannebecker J; Teckemeyer K; Ockenfeld K; Weber K; Becker B
    PLoS One; 2018; 13(8):e0200748. PubMed ID: 30096209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities.
    Rutala WA; Kanamori H; Gergen MF; Sickbert-Bennett EE; Weber DJ
    Infect Control Hosp Epidemiol; 2019 Mar; 40(3):380-382. PubMed ID: 30767810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different efficacies of common disinfection methods against candida auris and other candida species.
    Fu L; Le T; Liu Z; Wang L; Guo H; Yang J; Chen Q; Hu J
    J Infect Public Health; 2020 May; 13(5):730-736. PubMed ID: 32005617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of surface disinfectants and a micellic H
    Zatorska B; Moser D; Diab-Elschahawi M; Ebner J; Lusignani LS; Presterl E
    J Mycol Med; 2021 Dec; 31(4):101178. PubMed ID: 34388399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Disinfectants Against Candida auris and Other Candida Species.
    Cadnum JL; Shaikh AA; Piedrahita CT; Sankar T; Jencson AL; Larkin EL; Ghannoum MA; Donskey CJ
    Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1240-1243. PubMed ID: 28793937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin and hard surface disinfection against
    Omardien S; Teska P
    Front Med (Lausanne); 2024; 11():1312929. PubMed ID: 38384416
    [No Abstract]   [Full Text] [Related]  

  • 10. Demonstration of the yeasticidal efficacy of povidone-iodine-based commercial antiseptic solutions against Candida auris.
    Chesnay A; Bailly É; Desoubeaux G
    J Mycol Med; 2021 Dec; 31(4):101173. PubMed ID: 34271481
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of 23 commonly used liquid disinfectants against
    Haq MF; Pearlmutter BS; Cadnum JL; Donskey CJ
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):127-131. PubMed ID: 37528766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface disinfection challenges for Candida auris: an in-vitro study.
    Kean R; Sherry L; Townsend E; McKloud E; Short B; Akinbobola A; Mackay WG; Williams C; Jones BL; Ramage G
    J Hosp Infect; 2018 Apr; 98(4):433-436. PubMed ID: 29203448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of different drying conditions for the viability of Candida albicans present on carriers.
    Röhm-Rodowald E; Chojecka A; Jakimiak B; Wiercińska O; Ziemba B; Kanclerski K
    Rocz Panstw Zakl Hig; 2014; 65(1):49-54. PubMed ID: 24964579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris.
    Abdolrasouli A; Armstrong-James D; Ryan L; Schelenz S
    Mycoses; 2017 Nov; 60(11):758-763. PubMed ID: 28872735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging infectious diseases, focus on infection prevention, environmental survival and germicide susceptibility: SARS-CoV-2, Mpox, and Candida auris.
    Weber DJ; Rutala WA; Sickbert-Bennett E
    Am J Infect Control; 2023 Nov; 51(11S):A22-A34. PubMed ID: 37890950
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Romera D; Aguilera-Correa JJ; Gadea I; Viñuela-Sandoval L; García-Rodríguez J; Esteban J
    J Med Microbiol; 2019 Sep; 68(9):1353-1358. PubMed ID: 31271350
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival of Candida auris on environmental surface materials and low-level resistance to disinfectant.
    Dire O; Ahmad A; Duze S; Patel M
    J Hosp Infect; 2023 Jul; 137():17-23. PubMed ID: 37116661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model.
    Fakhim H; Vaezi A; Dannaoui E; Chowdhary A; Nasiry D; Faeli L; Meis JF; Badali H
    Mycoses; 2018 Jun; 61(6):377-382. PubMed ID: 29460345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative efficacy of antiseptics against Candida auris biofilms.
    Kean R; McKloud E; Townsend EM; Sherry L; Delaney C; Jones BL; Williams C; Ramage G
    Int J Antimicrob Agents; 2018 Nov; 52(5):673-677. PubMed ID: 29775686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.